搜索新闻
媒体联系

电子邮箱:id201@e-techco.com

联系电话:86-755-83209797

瑞士银行视察易特科(前海安测)“AI+医疗”

日期:2019-01-17 来源:易特科 浏览次数190657

1月17日,瑞士银行证券投行部TMT行业主管王进琎女士、副董事陈川先生、广州营业部总经理廖昕先生率领核心团队一行多人莅临易特科(前海安测)深圳总部实地视察AI医疗创新项目,交流指导企业IPO工作。易特科(前海安测)董事长兼CEO张贯京先生,董事宋云明博士、 CIO林国雄先生,总工程师兼投资部总经理高伟明博士等核心团队全程陪同视察,并向来访团队详细讲解了易特科(前海安测)AI医疗项目建设情况和进度。

期间,瑞士银行高管团队认真视察了产品研发实验室、产品陈列展示区及产品生产组装车间,仔细考察了易特科(前海安测)医疗智能化、智能检测设备、医疗信息化、健康信息化、区域卫生信息化等产品和解决方案。在产品展示中心,总工程师兼投资部总经理高伟明博士向瑞士银行高管团讲解汇报了易特科集团智慧医疗产品设计研发理念、产品技术先进性、目前市场前景及发展规划。高管团队对易特科集团科研创新能力表示高度肯定和赞许。




随后的座谈会上,易特科(前海安测)董事长兼CEO张贯京先生对瑞士银行高管团队此行表示热烈欢迎,并向代表团介绍了易特科集团的发展历程、业务开拓与发展概况,感谢瑞士银行长期以来对易特科集团的大力支持,表示希望双方未来可以在银企战略合作方面增强交流与合作。张贯京董事长提到,易特科集团是一家创新型企业,深耕医疗大健康行业,以最先进的人工智能、大数据、深度学习等技术和产品服务于医疗信息化、健康养老行业。我们希望与瑞士银行加强战略合作,将易特科集团打造为“独角兽”硬科技高新技术企业,快速迈进IPO。


随后,双方就如何加快推进公司上市工作,并将易特科集团打造成智慧行业内具有先进模范作用的企业进行了深入交谈。瑞士银行代表团也表达了与易特科集团未来的合作信心。代表团表示,易特科拥有持续的创新能力、深厚的技术积累和优质的客户服务,今后双方可以通过多种合作模式实现智慧医疗项目落地,支持易特科集团创新发展。双方联合合作,站在更高的战略高度,推动智慧医疗取得新的突破性进展,为国人带来更便捷高效、智能精准的AI医疗服务!

On January 17th, Ms. Wang Jinjin, Director of TMT Industry of UBS Securities Investment Bank, Mr. Chen Chuan, Deputy Director, and Mr. Liao Wei, General Manager of Guangzhou Sales Department led a group of people from the core team to visit E-Techco (Qianhai AnyCheck) Shenzhen Headquarters to inspect AI Medical innovation projects, exchange and guide corporate IPO work. Mr. Zhang Guanjing, Chairman and CEO of E-Techco (Qianhai AnyCheck), Dr. Song Yunming, Director of CIO, Mr. Lin Guoxiong, Chief Engineer and General Manager of Investment Department, Dr. Gao Weiming and other core teams accompanied the inspection and explained E-Techco to the visiting team in detail.

During the period, Swiss bank executive team carefully inspected the product development laboratory, the product display display area and the product production assembly workshop, and carefully examined E-Techco (Qianhai AnyCheck) medical intelligence, intelligent testing equipment, medical information, health information. Products and solutions such as chemical and regional health information. In the product display center, Dr. Gao Weiming, Chief Engineer and General Manager of the Investment Department, explained to the Swiss Bank's executive team the E-Techco Group's smart medical product design and development concept, product technology advancement, current market prospects and development plans. The executive team expressed high recognition and appreciation for E-Techco Group's research and innovation capabilities.

At the subsequent symposium, Mr. Zhang Guanjing, Chairman and CEO of E-Techco (Qianhai AnyCheck), extended a warm welcome to the Bank of Switzerland executive team and introduced the development history, business development and development of E-Techco Group. In general, I would like to thank Swiss Bank for its long-term support to E-Techco Group and expressed the hope that the two sides can enhance exchanges and cooperation in strategic cooperation between banks and enterprises in the future. Chairman Zhang Guanjing mentioned that E-Techco Group is an innovative enterprise that is deeply rooted in the medical and health industry and serves the medical information and health care industry with the most advanced technologies such as artificial intelligence, big data and deep learning. We hope to strengthen strategic cooperation with UBS and build E-Techco Group into a "unicorn" hard technology high-tech enterprise and quickly enter the IPO.

Subsequently, the two sides conducted in-depth talks on how to speed up the company's listing work and to make E-Techco Group an advanced model in the smart industry. The Swiss bank delegation also expressed confidence in the future cooperation with E-Techco Group. The delegation stated that E-Techco has continuous innovation capability, deep technical accumulation and high-quality customer service. In the future, both parties can realize the development of smart medical projects through various cooperation modes and support the innovation and development of E-Techco Group. The two sides will cooperate and stand at a higher strategic level to promote new breakthroughs in smart medical care and bring more convenient, efficient, intelligent and accurate AI medical services to Chinese people.